Article
ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings.
Journal of pediatric gastroenterology and nutrition - 1 Apr 2024
Indolfi Giuseppe, Gonzalez-Peralta Regino P, Jonas Maureen M, Sayed Manal Hamdy-El, Fischler Björn, Sokal Etienne, Wirth Stefan, Nicastro Emanuele
Abstract excerpt
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide, with more than three million viraemic adolescents and children. Treatment of adults with HCV infection and HCV-related liver disease has advanced considerably thanks to development and improvements in therapy. Direct-acting antiviral regimens are safe and effective. Three regimens with pangenotypic activity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
